Warren E. Regelmann

Risk Factors For Rate of Decline in Forced Expiratory Volume in One Second in Children and Adolescents with Cystic Fibrosis

Michael W. Konstan, Wayne J. Morgan, Steven M. Butler et al. · The Journal of Pediatrics · 2007 · 441 citations

Medicine, Child Health, Pediatrics +16

Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2–5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study

Jane C. Davies, Steve Cunningham, William T. Harris et al. · The Lancet Respiratory Medicine · 2016 · 345 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15

EFFECT OF EXTRACELLULAR SLIME SUBSTANCE FROM STAPHYLOCOCCUS EPIDERMIDIS ON THE HUMAN CELLULAR IMMUNE RESPONSE

Ernest D. Gray, Marjorie Verstegen, Georg Peters et al. · The Lancet · 1984 · 273 citations

Life Sciences, Immunology, Microbiology +8

Reduction of Sputum <i>Pseudomonas aeruginosa</i> Density by Antibiotics Improves Lung Function in Cystic Fibrosis More than Do Bronchodilators and Chest Physiotherapy Alone

Warren E. Regelmann, Greg R. Elliott, Warren J. Warwick et al. · American Review of Respiratory Disease · 1990 · 260 citations

Medicine, Pharmacotherapy, Respiratory Therapy +17

Pulmonary exacerbations in cystic fibrosis

Harvey Rabin, Steven M. Butler, Mary Ellen B. Wohl et al. · Pediatric Pulmonology · 2004 · 250 citations

Medicine, Infectious Diseases, Pharmacotherapy +16